|
China’s pharmaceutical market is currently ninth largest worldwide and worth approximately $20 billion. With analysts predicting this market to be fifth largest by 2010, one cannot ignore China’s potential. This webcast will provide an overview of drug registration in China as well as discuss the most recent regulatory issues of the Chinese State Food and Drug Administration (SFDA). This 90-minute session will include a 60-minute presentation, followed by 30 minutes of Q&A.
Click here to see a sample page of our webcast presentation.
The following topics will be covered in this webcast:
- Overview of China Healthcare
- China Pharmaceutical Market Industry Overview
- Drug Registration Policy
- Pharmaceutical Manufacturing Regulations
- Classification of Drugs
- Drug Registration Application
- Drug Pricing
- Clinical Trials
- Requirements for product inserts, labeling and packaging
- Good Manufacturing Practice (GMP)
- Good Clinical Practice (GCP)
- Good Laboratory Practice (GLP)
- Post-marketing surveillance and quality control
- Intellectual Property
Click here to purchase a CD which includes the audio and PowerPoint presentation
|
Print
This Page 